ReviewCancers2025

An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.

Akihiro Matsukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.